Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Euna | - |
dc.contributor.author | Yoon, Juhee | - |
dc.contributor.author | Pae, Ae Nim | - |
dc.contributor.author | Rhim, Hyewhon | - |
dc.contributor.author | Park, Woo-Kyu | - |
dc.contributor.author | Kong, Jae Yang | - |
dc.contributor.author | Choo, Hea-Young Park | - |
dc.date.accessioned | 2024-01-20T20:00:39Z | - |
dc.date.available | 2024-01-20T20:00:39Z | - |
dc.date.created | 2021-09-02 | - |
dc.date.issued | 2010-02-15 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/131713 | - |
dc.description.abstract | A novel series of 5-HT2A ligands that contain a (phenylpiperazinyl-propyl)arylsulfonamides skeleton was synthesized. Thirty-seven N-(cycloalkylmethyl)-4-methoxy-N-(3-(4-arylpiperazin-1-yl)propyl)arylsulfonamide and N-(4-(4-arylpiperazin-1-yl)butan-2-yl)-arylsulfonamide compounds were obtained. The binding of these compounds to the 5-HT2A, 5-HT2C, and 5-HT7 receptors was evaluated. Most of the compounds showed IC50 values of less than 100 nM and exhibited high selectivity for the 5-HT2A receptor. Among the synthesized compounds, 16a and 16d showed good affinity at 5-HT2A (IC50 = 0.7 nM and 0.5 nM) and good selectivity over 5-HT2C (50-100 times) and 5-HT7 (1500-3000 times). (C) 2010 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | SEROTONIN | - |
dc.subject | DERIVATIVES | - |
dc.subject | SCHIZOPHRENIA | - |
dc.subject | AFFINITY | - |
dc.title | Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT2A receptor antagonists | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmc.2009.12.067 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.18, no.4, pp.1665 - 1675 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 18 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1665 | - |
dc.citation.endPage | 1675 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000274425500032 | - |
dc.identifier.scopusid | 2-s2.0-75849120790 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | SEROTONIN | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.subject.keywordPlus | AFFINITY | - |
dc.subject.keywordAuthor | 5-HT2A receptor antagonists | - |
dc.subject.keywordAuthor | Piperazine | - |
dc.subject.keywordAuthor | Sulfonamide | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.